David Kirske
Director Financiero/CFO en CTI BIOPHARMA CORP. .
Cargos activos de David Kirske
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| CTI BIOPHARMA CORP. | Director Financiero/CFO | 26/09/2017 | - |
| Secretario Corporativo | - | - |
Historial de carrera de David Kirske
Antiguos cargos conocidos de David Kirske.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| HELIX BIOMEDIX, INC. | Director Financiero/CFO | - | 23/06/2008 |
| Redhook Ale Brewery, Inc. | Comptroller/Controller/Auditor | - | - |
| Treasurer | - | - | |
| F5, INC. | Comptroller/Controller/Auditor | - | - |
| Treasurer | - | - |
Formación de David Kirske.
| University of Puget Sound | Undergraduate Degree |
Estadísticas
Internacional
| Estados Unidos | 6 |
Operativa
| Director of Finance/CFO | 2 |
| Comptroller/Controller/Auditor | 2 |
| Treasurer | 2 |
Sectorial
| Health Technology | 3 |
| Consumer Services | 2 |
| Technology Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 2 |
|---|---|
| HELIX BIOMEDIX, INC. | Health Technology |
| F5, INC. | Technology Services |
| Empresas privadas | 2 |
|---|---|
CTI BioPharma Corp.
 CTI BioPharma Corp. Pharmaceuticals: MajorHealth Technology CTI BioPharma Corp. is a biopharmaceutical company, which engages in the development, acquisition, and commercialization of novel targeted therapies for blood-related cancers. It focuses on evaluating pacritinib, its sole product candidate currently in active development, for the treatment of adult patients with myelofibrosis. The company was founded by James A. Bianco, Jack W. Singer, and Louis A. Bianco in September 1991 and is headquartered in Seattle, WA. | Health Technology |
| Redhook Ale Brewery, Inc. | Consumer Non-Durables |
- Bolsa de valores
- Insiders
- David Kirske
- Experiencia
